(Q45739449)
Statements
Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response (English)
Yang J
Tao Q
Flinn IW
Murray PG
Post LE
Ma H
Piantadosi S
Caligiuri MA